CCBC SHARES KNOWLEDGE AROUND THE WORLD

As a leader in research and innovation in the cord blood and cellular therapy industries, the Cleveland Cord Blood Center shares our knowledge and experiences in cord blood banking, research and cellular therapy throughout the U.S and globally with industry thought leaders, government agencies, the medical community and researchers. Past and future presentations and current stories featuring CCBC subject experts include:

Marcie Finney, Executive Director, M.S., MBA

  • Maude Dumont-Lagacė, Albert Feghaly, Marie-Christine Meunier, Marcie Finney, Wouter Van’t Hof, Emeline Masson Frenet, Guy Sauvageau, Sandra Cohen, UM171 expansion of cord blood improves donor availability and HLA matching for all patients, including minorities, Transplantation and Cellular Therapy (2022), doi: https://doi.org/10.1016/j.jtct.2022.03.016
  • Advanced Therapies Live, May 25, 2022. ExCel Center, London, England. Use of Cord Blood as a Starting Material for Cell Therapy
  • Cord Blood Connect International Congress, September 23, 2021.Panel: Cord Blood Banking Sustainability: Strategies for the Future, U.S. Public Bank Sustainability Strategies: Cleveland Perspective  
  • Cord Blood Connect International Congress, September 30, 2021. Panel Moderator: Perinatal Tissue as Source Material for Novel Therapies
  • Do, Js., Zwick, D., Kenyon, J.D. et al.  Mesenchymal stromal cell mitochondrial transfer to human induced T-regulatory cells mediates FOXP3 stability, Sci Rep 11, 10676 (2021). https://doi.org/10.1038/s41598-021-90115-8
  • Advanced Therapies Congress & Expo 2021, Wednesday May 19, 2021, Roundtable: The future of cord blood use. Business models, new uses for CB, ethics of pioneering new trials, updating the delivery room, panel featuring Marcie R. Finney, Executive Director, Cleveland Cord Blood Center
  • World Cord Blood Day, November 17, 2020, Q&A Session: Impact of COVID-19 on Cord Blood
  • AABB Annual Meeting, October 3-6, 2020, Public Awareness and Recruitment of Cord Blood Donors for Public Programs
  • 2020 Cord Blood Connect International Congress, Cord Blood Association, September 17, 2020, Banking Cord Blood in the Era of COVID-19
  • Advanced Therapies Congress & Expo, September 11, 2020, Diverse Use of Cord Blood for Hematological and Non-hematological Indications
  • Annual Arizona Cord Blood Conference, August 10, 2020, Driving Cord Blood Utilization through Research and Development
  • Cord Blood Advisory Group, June 2020, COVID-19 Impact on Public Cord Blood Banks
  • Advisory Council on Blood Stem Cell Transplantation, Human Resources and Services Administration, April 27, 2020, COVID-19: Impact on Cord Blood Banking Cleveland Experience
  • Ohio University Heritage College of Osteopathic Medicine, December 5, 2019, Public Umbilical Cord Blood Banking – The Role of Providers
  • Cord Blood Connect Conference (Miami, FL), September 13, 2019, Consenting for Cord Blood Donation in the Modern Era of Commercialization
  • Advisory Committee on Blood and Stem Cell Transplantation (Robert Walsh, Executive Secretary for the U.S. Department of Health and Human Services’ (HHS) Advisory Council on Blood Stem Cell Transplantation (ACBSCT) webinar, September 10, 2019, The Diverse Use of Cord Blood for Hematologic and Non-hematologic Indications
  • Save the Cord Foundation – Share the Science webinar, September 5, 2019, Driving Cord Blood Utilization through Research & Development
  • World Advanced Therapies & Regenerative Medicine Congress & Expo. (London), May 17, 2019, Driving Public Banked Cord Blood Inventory Utilization through Research & Development

  • Maude Dumont-Lagacė, Albert Feghaly, Marie-Christine Meunier, Marcie Finney, Wouter Van’t Hof, Emeline Masson Frenet, Guy Sauvageau, Sandra Cohen, UM171 expansion of cord blood improves donor availability and HLA matching for all patients, including minorities, Transplantation and Cellular Therapy (2022), doi: https://doi.org/10.1016/j.jtct.2022.03.016
  • Do, Js., Zwick, D., Kenyon, J.D. et al.  Mesenchymal stromal cell mitochondrial transfer to human induced T-regulatory cells mediates FOXP3 stability, Sci Rep 11, 10676 (2021). https://doi.org/10.1038/s41598-021-90115-8
  • 2021 Cell & Gene Therapy Bioprocessing & Commercialization Digital Week, February 17, 2021 presentation: A Cell Therapy Media Fill Protocol for Validation of Aseptic Processing of Cord Blood
  • Cell & Gene Therapy Insights, A cell therapy media fill protocol for validation of aseptic processing of cord blood, November 24, 2020, Copyright ©2020 Kim Vincent, Dawn Thut, Sara Shields, Wouter Van’t Hof, Faith DeDino, Denise DiNello, Susan Whitmer, Michelle Adamo, David Starkey, Kara Evans, Molly Walker. Published by Cell and Gene Therapy Insights under Creative Commons License Deed CC BY NC ND 4.0.
  • Cell & Gene Therapy Insights, Interview with Wouter Van’t Hof: How will COVID-19 impact the cord blood banking sector, June 5, 2020, Copyright© 2020 Van’t Hof W. Published by Cell and Gene Therapy Insights under Creative Commons License Deed CC BY NC ND 4.0
  • 2019 Cell & Gene Therapy Bioprocessing & Commercialization Meeting (Boston, MA), September 12, 2019, panel discussion: CMO Landscapes for New Product Initiatives: Novel Outsourcing Models
  • 2019 Vein-to-vein: Commercializing cell therapies: Taking R&D success to industrial scale (Boston, MA), November 20-21, 2019, Lessons learned from the commercialization of Stem Cell therapies – Case study from working with the FDA to approve the manufacturing of Clevecord

  • Cell & Gene Therapy Insights, A cell therapy media fill protocol for validation of aseptic processing of cord blood, November 24, 2020, Copyright ©2020 Kim Vincent, Dawn Thut, Sara Shields, Wouter Van’t Hof, Faith DeDino, Denise DiNello, Susan Whitmer, Michelle Adamo, David Starkey, Kara Evans, Molly Walker. Published by Cell and Gene Therapy Insights under Creative Commons License Deed CC BY NC ND 4.0.
  • 2020 Cord Blood Connect International Congress, Cord Blood Association, September 17, 2020, Operational Management and Readiness of Cleveland Cord Blood Center Dry Shipper Fleet for HPC, Cord Blood Distribution
  • International Society of Cell & Gene Therapy (ISCT) conference (Madison, WI), poster presentation, September 14, 2019, Evaluation of the Impact of Internal and External Factors on the Processing Rate of Cord Blood Units at the Cleveland Cord Blood Center

  • Do, Js., Zwick, D., Kenyon, J.D. et al.  Mesenchymal stromal cell mitochondrial transfer to human induced T-regulatory cells mediates FOXP3 stability, Sci Rep 11, 10676 (2021). https://doi.org/10.1038/s41598-021-90115-8
  • Cell & Gene Therapy Insights, A cell therapy media fill protocol for validation of aseptic processing of cord blood, November 24, 2020, Copyright ©2020 Kim Vincent, Dawn Thut, Sara Shields, Wouter Van’t Hof, Faith DeDino, Denise DiNello, Susan Whitmer, Michelle Adamo, David Starkey, Kara Evans, Molly Walker. Published by Cell and Gene Therapy Insights under Creative Commons License Deed CC BY NC ND 4.0.
  • 2020 Cord Blood Connect International Congress, Cord Blood Association, September 17, 2020, Kathy Bobik-Kurz, COVID-19 and its Impact on Collection, Processing of Cord Blood Units at the Cleveland Cord Blood Center
  • Northeast Ohio Innovative STEM Expo (NOISE), April 13, 2019
  • Greater Cleveland Stem Festival, October 19, 2019
    Sara Shields & Daniel Zwick, Ph.D. speakers: Cleveland Cord Blood Center: Amazing Facts, Exciting Future